Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences , Monash University , Parkville , Victoria 3052 , Australia.
Departments of Pharmacology & Chemistry, Vanderbilt Center for Neuroscience Drug Discovery , Vanderbilt University , Nashville , Tennessee 37232 , United States.
ACS Chem Neurosci. 2018 Jul 18;9(7):1818-1828. doi: 10.1021/acschemneuro.8b00136. Epub 2018 Apr 30.
Recent years have seen a large increase in the discovery of allosteric ligands targeting muscarinic acetylcholine receptors (mAChRs). One of the challenges in screening such compounds is to understand their mechanisms of action and define appropriate parameter estimates for affinity, cooperativity and efficacy. Herein we describe the mechanisms of action and structure-activity relationships for a series of "pan-G-coupled" muscarinic acetylcholine (ACh) receptor (mAChR) positive allosteric modulators (PAMs). Using a combination of radioligand binding, functional inositol phosphate accumulation assays, receptor alkylation and operational data analysis, we show that most compounds in the series derive their variable potency and selectivity from differential cooperativity at the M, M and M mAChRs. None of the PAMs showed greater than 10-fold subtype selectivity for the agonist-free receptor, but VU6007705, VU6007678, and VU6008555 displayed markedly increased cooperativity compared to the parent molecule and M mAChR-preferring PAM, ML380 (αβ > 100), in the presence of ACh. Most of the activity of these PAMs derives from their ability to potentiate ACh binding affinity at mAChRs, though VU6007678 was notable for also potentiating ACh signaling efficacy and robust allosteric agonist activity. These data provide key insights for the future design of more potent and subtype-selective mAChR PAMs.
近年来,针对毒蕈碱型乙酰胆碱受体 (mAChR) 的变构配体的发现大量增加。筛选此类化合物的挑战之一是了解其作用机制并确定亲和力、协同性和效力的适当参数估计。在此,我们描述了一系列“pan-G-coupled”毒蕈碱乙酰胆碱 (ACh) 受体 (mAChR) 正变构调节剂 (PAM) 的作用机制和结构-活性关系。我们使用放射性配体结合、功能性肌醇磷酸盐积累测定、受体烷基化和操作数据分析的组合,表明该系列中的大多数化合物的可变效力和选择性来自于在 M、M 和 M mAChRs 上的不同协同作用。该系列中的没有一种 PAM 对无激动剂受体显示出大于 10 倍的亚型选择性,但与母体分子和 M mAChR 偏好的 PAM ML380(αβ > 100)相比,VU6007705、VU6007678 和 VU6008555 在 ACh 存在下显示出明显增加的协同作用。这些 PAM 的大部分活性来自于它们增强 mAChR 上 ACh 结合亲和力的能力,尽管 VU6007678 还增强了 ACh 信号传导效力和强大的变构激动剂活性。这些数据为更有效和亚型选择性 mAChR PAM 的未来设计提供了关键见解。